Marker Therapeutics Files 8-K
Ticker: MRKR · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1094038
| Field | Detail |
|---|---|
| Company | Marker Therapeutics, Inc. (MRKR) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-filing
TL;DR
Marker Therapeutics just filed an 8-K on 6/16/25 - looks like a material definitive agreement.
AI Summary
On June 16, 2025, Marker Therapeutics, Inc. entered into a Material Definitive Agreement. The company, formerly known as TAPIMMUNE INC. and GENEMAX CORP, is based in Houston, TX, and operates in the Pharmaceutical Preparations industry. This filing also includes other events and financial statements.
Why It Matters
This 8-K filing indicates significant corporate activity for Marker Therapeutics, Inc., potentially involving new agreements or material changes that could impact its business operations and stock.
Risk Assessment
Risk Level: medium — 8-K filings often signal important corporate events, which can introduce volatility and risk depending on the nature of the disclosed information.
Key Players & Entities
- Marker Therapeutics, Inc. (company) — Registrant
- TAPIMMUNE INC. (company) — Former Company Name
- GENEMAX CORP (company) — Former Company Name
- June 16, 2025 (date) — Date of earliest event reported
- 2450 Holcombe Blvd (location) — Business Address
FAQ
What is the nature of the Material Definitive Agreement entered into by Marker Therapeutics, Inc. on June 16, 2025?
The filing indicates Marker Therapeutics, Inc. entered into a Material Definitive Agreement on June 16, 2025, but the specific details of this agreement are not provided in the excerpt.
What were Marker Therapeutics, Inc.'s former company names?
Marker Therapeutics, Inc. was formerly known as TAPIMMUNE INC. and GENEMAX CORP.
Where is Marker Therapeutics, Inc. located?
Marker Therapeutics, Inc. is located at 2450 Holcombe Blvd, Suite BCM-A, MS: BCM251, Houston, TX 77021.
What is the Standard Industrial Classification code for Marker Therapeutics, Inc.?
The Standard Industrial Classification code for Marker Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date for this 8-K report?
This 8-K report was filed as of June 17, 2025, with the earliest event reported on June 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Marker Therapeutics, Inc. (MRKR).